Article Details
Retrieved on: 2021-11-12 04:37:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Much of the expense of a monoclonal antibody therapy comes from manufacturing it. Because the patient's immune system becomes the manufacturing plant ...
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here